Meyko begins technical studies to industrialise their product

Meyko accompanies asthmatic children to improve controller medication adherence

Meyko, a start-up supported by the Innovation Journey initiative of EIT Health France, has begun the technical studies necessary to industrialise their product that is designed to assist children with asthma.

Meyko is an amusing and an interactive companion that encourages your child to follow their daily medicine routine. It’s a medication reminder that fits children’s needs. Meyko is also connected to a mobile app intended to reassure parents daily. It allows parents to monitor the medication routine and share treatment reports with their doctor. By adopting Meyko, children take care of themself. Meyko allows them to be more involved in their own care. Among all the different chronic diseases, asthma has the worst adherence rate. Meyko aims to improve medication adherence to improve the young patient’s daily life.

This French start-up also works with all those involved in the child’s care process in order to propose a solution that is best adapted to the real need of patients and caregivers. Meyko is integrated into the incubator Atlanpole based in Nantes.

With the €25 000 of EIT Health Grant they earned during the 29th June pitch-competition finals of “Innovation Journey from Education to Business” in the buildings of Cap Digital, another partner of EIT Health France, they were able to progress on their technical choice.

Meyko participated in the final pitch competition of the Innovation Journey, and presented their current stage of development. They currently work in co-construction with all those involved in the child’s care process in order to propose a solution that is best adapted to the real needs of patients and caregivers.

Click here to visit the website.